Blood plasma VEGFA analysis in the AVAGAST randomized study of first-line bevacizumab (bev) + capecitabine/cisplatin (cape/cis) in patients (pts) with advanced gastric cancer (AGC) Meeting Abstract
| Authors: | Shah, M. A.; Kang, Y.; Ohtsu, A.; Roman, L.; Nunes, J.; Li, C.; Delmar, P.; Langer, B.; Scherer, S. J.; Van Cutsem, E. |
| Abstract Title: | Blood plasma VEGFA analysis in the AVAGAST randomized study of first-line bevacizumab (bev) + capecitabine/cisplatin (cape/cis) in patients (pts) with advanced gastric cancer (AGC) |
| Meeting Title: | 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011) |
| Journal Title: | European Journal of Cancer |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2011 Sep 23-27 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-09-01 |
| Start Page: | S173 |
| End Page: | S174 |
| Language: | English |
| ACCESSION: | WOS:000295752800602 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(11)70908-X |
| Notes: | Meeting Abstract: 1415 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos" |
